439 related articles for article (PubMed ID: 6992594)
1. The prostanoids in hemostasis and thrombosis: a review.
Smith JB
Am J Pathol; 1980 Jun; 99(3):743-804. PubMed ID: 6992594
[No Abstract] [Full Text] [Related]
2. Prostaglandin H2 in human platelet activation: coactivator and substitute for thromboxane A2.
Hornberger WB; Patscheke H
Prog Clin Biol Res; 1989; 301():315-9. PubMed ID: 2798452
[TBL] [Abstract][Full Text] [Related]
3. [Kinetic mechanisms of enzyme activity of the thromboxane synthetase system. Thromboxane synthetase of human platelets].
Basevich VV; Mevkh AT; Varfolomeev SD
Biokhimiia; 1984 Sep; 49(9):1538-45. PubMed ID: 6440597
[TBL] [Abstract][Full Text] [Related]
4. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade, combined in one molecule.
De Clerck F; Beetens J; de Chaffoy de Courcelles D; Vercammen E; Freyne E; Janssen PA
Prog Clin Biol Res; 1989; 301():567-72. PubMed ID: 2529556
[No Abstract] [Full Text] [Related]
5. Platelet thromboxane A2/endoperoxide (TXA2/PGH2) receptors in type I diabetes mellitus.
Jaschonek K; Faul C; Weisenberger H; Krönert K; Schröder H; Renn W
Thromb Haemost; 1989 Jun; 61(3):535-6. PubMed ID: 2529665
[No Abstract] [Full Text] [Related]
6. Desensitisation of human platelets against stimulation by thromboxane mimics--reduction in receptor capacity and loss of functional response.
Thierauch KH; Gabriel D; Prior G; Schillinger E
Biomed Biochim Acta; 1988; 47(10-11):S75-8. PubMed ID: 2470362
[TBL] [Abstract][Full Text] [Related]
7. The biological role of thromboxane A2 in the process of hemostasis and thrombosis; pharmacology and perspectives of therapeutical use of thromboxane synthetase inhibitors and receptor PGH2/TXA2 antagonists.
Radomski M
Acta Physiol Pol; 1985; 36(3):153-64. PubMed ID: 3915630
[TBL] [Abstract][Full Text] [Related]
8. Transient concentrations and agonist potency of PGH2 in platelet activation by endogenous arachidonate.
Hornberger W; Patscheke H
Eicosanoids; 1989; 2(4):241-8. PubMed ID: 2517034
[TBL] [Abstract][Full Text] [Related]
9. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.
Golino P; Rosolowsky M; Yao SK; McNatt J; De Clerck F; Buja LM; Willerson JT
J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320
[TBL] [Abstract][Full Text] [Related]
10. Evidence that prostaglandin endoperoxides can induce platelet aggregation in the absence of thromboxane A2 production.
Hornby EJ; Skidmore IF
Biochem Pharmacol; 1982 Mar; 31(6):1158-60. PubMed ID: 7200773
[No Abstract] [Full Text] [Related]
11. Overview of physiological and pathophysiological effects of thromboxane A2.
Ogletree ML
Fed Proc; 1987 Jan; 46(1):133-8. PubMed ID: 2948837
[TBL] [Abstract][Full Text] [Related]
12. Roles of thromboxanes in gastrointestinal physiopathology.
Bennett TA
Int J Tissue React; 1983; 5(3):237-9. PubMed ID: 6686219
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis.
Fitzgerald DJ; Fragetta J; FitzGerald GA
J Clin Invest; 1988 Nov; 82(5):1708-13. PubMed ID: 3183064
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.
Moncada S; Vane JR
Pharmacol Rev; 1978 Sep; 30(3):293-331. PubMed ID: 116251
[No Abstract] [Full Text] [Related]
15. Formation by phospholipase A2 of prostaglandins and endoperoxides in platelets of normal and essential fatty acid-deficient rats.
Vincent JE; Zijlstra FJ
Adv Prostaglandin Thromboxane Res; 1978; 3():143-6. PubMed ID: 655005
[No Abstract] [Full Text] [Related]
16. Inhibitors of thromboxane synthase in human platelets.
Alusy UD; Hammarström S
FEBS Lett; 1977 Oct; 82(1):107-10. PubMed ID: 913565
[No Abstract] [Full Text] [Related]
17. Effects of the prostaglandin H2/thromboxane A2 antagonist BM 13.177 on human platelets.
Patscheke H; Stegmeier K
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():371-3. PubMed ID: 3159225
[No Abstract] [Full Text] [Related]
18. Thromboxane A2 and prostaglandin H2 form covalently linked derivatives with human serum albumin.
Maclouf J; Kindahl H; Granström E; Samuelsson B
Adv Prostaglandin Thromboxane Res; 1980; 6():283-6. PubMed ID: 7386268
[No Abstract] [Full Text] [Related]
19. Biosynthesis and biological properties of prostaglandin endoperoxides and thromboxane A2.
Svensson J
Acta Biol Med Ger; 1978; 37(5-6):731-40. PubMed ID: 742285
[TBL] [Abstract][Full Text] [Related]
20. Photoaffinity labelling of the human platelet thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptor.
Mais DE; Halushka PV
Prog Clin Biol Res; 1989; 301():303-7. PubMed ID: 2529550
[No Abstract] [Full Text] [Related]
[Next] [New Search]
